Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has announced a new securities purchase plan with the intent to issue a maximum of 36,363,636 ordinary fully paid shares. The record date for the offer is set for September 11, 2024, with the offer closing on October 7, 2024, and the issue date on October 10, 2024. This move by the pharmaceutical company aims to expand its financial horizons, potentially stirring interest among investors in the stock market.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.
